rofecoxib has been researched along with Elevated ICP (Intracranial Pressure) in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rofecoxib is a selective cyclo-oxygenase (COX)-2 inhibitor, now being increasingly used in place of nonselective nonsteroidal anti-inflammatory drugs (NSAIDs)." | 5.33 | Intracranial hypertension induced by rofecoxib. ( Jacob, S; Rajabally, YA, 2005) |
| "Rofecoxib is a selective cyclo-oxygenase (COX)-2 inhibitor, now being increasingly used in place of nonselective nonsteroidal anti-inflammatory drugs (NSAIDs)." | 1.33 | Intracranial hypertension induced by rofecoxib. ( Jacob, S; Rajabally, YA, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacob, S | 1 |
| Rajabally, YA | 1 |
1 other study available for rofecoxib and Elevated ICP (Intracranial Pressure)
| Article | Year |
|---|---|
Intracranial hypertension induced by rofecoxib.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Hum | 2005 |